No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Asset Management
This investment vehicle aims to achieve long-term capital appreciation for its shareholders. It primarily allocates a minimum of 80% of its total assets to equities, predominantly common stock, of companies operating in the health sciences sector and associated industries. This encompasses businesses involved in areas such as healthcare equipment and supplies, service providers, biotechnology, and pharmaceuticals. A key strategy involves concentrating over 25% of its portfolio in these health sciences or related sectors. Furthermore, the fund may invest in companies situated in non-U.S. countries.
www.blackrock.com/us/individual/products/227455/blackrock-health-sciences-opps-service-cl-fundNo one on the platform currently holds SHISX.
No tracked institution reports a position in SHISX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-22 | $6.4645 | 2026-07-23 |
| 2025-12-09 | $3.0180 | 2025-12-09 |
| 2025-07-17 | $3.8366 | 2025-07-17 |
| 2024-12-11 | $3.2147 | 2024-12-11 |
| 2024-07-18 | $2.4913 | 2024-07-18 |
| 2023-12-07 | $1.1318 | 2023-12-07 |
No one on the platform has traded SHISX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| SHISXBlackRock Health Sciences Opportunities Portfolio Service Shares | $63.94 | -0.11% | $6.4B | — |
| FSPHXFidelity Select Health Care Portfolio | $29.29 | +0.07% | $6.8B | — |
| LMGNXClearBridge International Growth I | $72.93 | -0.37% | $7.1B | — |
| PRPFXPermanent Portfolio Permanent I | $78.17 | +0.13% | $7.4B | — |
| RBAIXT. Rowe Price Balanced I Class | $29.93 | -0.33% | $5.3B | — |
| SHSAXBlackRock Health Sciences Opportunities Portfolio Investor A Shares | $63.51 | -0.11% | $6.4B | — |
| SHSCXBlackRock Health Sciences Opportunities Portfolio | $47.27 | -0.11% | $6.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
This investment vehicle aims to achieve long-term capital appreciation for its shareholders. It primarily allocates a minimum of 80% of its total assets to equities, predominantly common stock, of companies operating in the health sciences sector and associated industries. This encompasses businesses involved in areas such as healthcare equipment and supplies, service providers, biotechnology, and pharmaceuticals. A key strategy involves concentrating over 25% of its portfolio in these health sciences or related sectors. Furthermore, the fund may invest in companies situated in non-U.S. countries.